RTX Corp (NYSE:RTX) stock is up 1.9% to trade at $195.78 today, after the defense contractor reported better-than-expected third-quarter results and raised its full-year outlook. RTX posted adjusted ...
The $20-per-ADS all-cash acquisition agreement follows Phase 2 progress for Divesiran and is expected to close in the first quarter of 2027, subject to shareholder, court and regulatory approvals.
ZUG, Switzerland and BOSTON, Oct. 19, 2026 (GLOBE NEWSWIRE)-- CRISPR Therapeutics (Nasdaq: CRSP) today announced that its Chief Financial Officer, Raju Prasad, Ph.D., will be stepping down from the ...
Latest addition to Resmed’s growing fabric mask portfolio combines a soft, breathable fabric cushion with a minimalist design for greater comfort and choice SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE)-- ...
SAN JOSE, Calif., Oct. 19, 2026 /PRNewswire/ -- Sanmina Corporation (NASDAQ: SANM) announced today that it will host its fourth quarter and fiscal year 2026 earnings conference call on Monday, ...
The oncology company will disclose early-stage results for investigational cancer therapies alongside updated Phase 3 TEVIMBRA combination data, providing several clinical catalysts during the October ...
MEMPHIS, Tenn., Oct. 19, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) (or "First Horizon") is pleased to announce that Senior Executive Vice President and Chief Operating Officer Tammy ...
The capital restructuring converts legacy preferred securities into rights to receive ordinary shares while Freight Technologies advances its transition toward recurring AI-powered logistics software ...
Nebius Group (NASDAQ:NBIS) shares gained 3.6% in premarket trading on Monday after Truist analysts reiterated their Buy rating on the company and Nebius announced a $10 million programme supporting ...
Intel (NASDAQ:INTC) shares gained nearly 4% in premarket trading on Monday after JPMorgan upgraded the semiconductor manufacturer from Underweight to Neutral and the company disclosed an agreement to ...
Poster presentation to highlight the Phase 1a clinical evaluation of TTX-MC138 in patients with advanced solid tumors BOSTON, Oct. 19, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), ...
CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM
NASHVILLE, Tenn., Oct. 19, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-driven biopharmaceutical company advancing new therapies that address significant unmet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results